Ovidrel

Ovidrel is genetically engineered form of human chorionic gonadotropin (hCG) which is used to trigger ovulation in women undergoing infertility treatment. Ovidrel is given as a subcutaneous injection and comes in a premixed syringe. Ovulation usually occurs between 36 and 40 hours after ovidrel is given. In women undergoing an intrauterine insemination (IUI), the procedure is performed 38-40 hours after the ovidrel injection. In women undergoing IVF, the egg retrieval is performed approximately 36 hours after the ovidrel injection. Ovidrel will cause a urine pregnancy test to be positive. Therefore, if you have taken ovidrel, you should not do a urine pregnancy test for at least 12 days after the injection as you may get a false positive result.

For more information on ovidrel you may visit the Serono pharmaceutical website.